NLK is chronically hyper-activated in the erythroid progenitors of DBA patients, and NLK inhibition improves erythropoiesis in in vitro ribosome insufficient DBA models (1, 14, 19, 20). The gene discussed is NLK; the disease is Diamond-Blackfan anemia.